Corona Virus Infection
237
5
8
134
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
33 trials with published results (14%)
Research Maturity
134 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.1%
24 terminated out of 237 trials
84.8%
-1.7% vs benchmark
11%
26 trials in Phase 3/4
25%
33 of 134 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 134 completed trials
Clinical Trials (237)
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)
Long Term Outcomes of Patients With COVID-19
Trial of Treatments for COVID-19 in Hospitalized Adults
SPI-1005 Treatment in Severe COVID-19 Patients
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction
An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
Kidney in Coronavirus Disease 2019 Registry
A Study of Baricitinib (LY3009104) in Children With COVID-19
French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study
A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults
Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19
Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study